As pharma SMEs and biotechs grow, pharmacovigilance systems that once worked well can quickly become a bottleneck. This white paper breaks down how to build a pharmacovigilance (PV) setup that scales with your business, without losing compliance or control.
阅读更多
Expanding across Europe introduces complex pharmacovigilance requirements. Learn how EU PV systems can scale while integrating national roles and regulatory obligations.
阅读更多
AI is transforming pharmacovigilance processes from case processing and literature monitoring to signal detection. Discover how AI and NLP can enhance efficiency, compliance, and regulatory intelligence.
阅读更多
ICH E2D(R1) introduces new expectations for ODCS, PSPs, MRPs and digital platforms. Learn what MAHs must implement by 18 March 2026 to ensure pharmacovigilance compliance.
阅读更多
As European SMEs and biotechs expand, PV governance must scale to maintain EU-QPPV oversight and inspection readiness. Learn how to build a scalable pharmacovigilance system.
阅读更多
Learn how to scale pharmacovigilance across Europe efficiently by managing data, systems, and people while maintaining compliance with Good Pharmacovigilance Practices (GVP).
阅读更多
How to choose the right pharmacovigilance operating model (centralized, hybrid, decentralized) to scale smart across Europe while staying compliant.
阅读更多
Global PV success requires more than compliance. Discover how hybrid pharmacovigilance models help pharma companies meet local regulatory demands and build patient trust.
阅读更多
The European Commission has amended Regulation (EU) No 520/2012 on pharmacovigilance. The update strengthens oversight of outsourced PV activities, clarifies EudraVigilance monitoring, and aligns processes with international data standards (IDMP, MedDRA, Standard Terms).
阅读更多
Learn how to optimize pharmacovigilance systems and outsource strategically to turn compliance into business growth.
阅读更多
Learn how technovigilance ensures medical device safety through post-market surveillance, tackling risks, compliance, and best practices.
阅读更多
